Ligand Pharmaceuticals Incorporated (LGNZZ)
OTCMKTS · Delayed Price · Currency is USD
0.1200
0.00 (0.00%)
At close: Jul 16, 2025
Ligand Pharmaceuticals Market Cap
Ligand Pharmaceuticals has a market cap or net worth of $2.50 billion as of July 17, 2025. Its market cap has increased by 69.11% in one year.
Market Cap
2.50B
Enterprise Value
2.30B
Revenue
181.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.12
Market Cap Chart
Since November 25, 1994, Ligand Pharmaceuticals's market cap has increased from 76.19M to 2.50B, an increase of 3,182.72%. That is a compound annual growth rate of 12.06%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 857.64M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 553.58M |
| Glass House Brands | 545.56M |
| CytoDyn | 394.14M |
| American Oncology Network | 343.79M |